Ischemic stroke, a condition characterized by a blockage of blood flow to the brain, poses a significant threat to neuronal health. The prompt and effective management of this condition is critical to minimize brain damage and improve patient outcomes. Vinpocetine, a compound with a rich history in cerebrovascular research, offers a promising avenue for therapeutic intervention. NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of high-quality Vinpocetine, supporting vital research into its role in ischemic stroke.
Vinpocetine's therapeutic utility in ischemic stroke is attributed to its diverse pharmacological actions. Its capacity as a selective inhibitor of phosphodiesterase type 1 (PDE1) leads to increased intracellular levels of cyclic nucleotides, influencing neuronal signaling and improving cerebral blood flow. This enhancement of cerebrovascular function is paramount in counteracting the effects of ischemia, ensuring that brain tissue continues to receive essential oxygen and nutrients. The focus on vinpocetine ischemic stroke management is well-supported by these physiological effects.
Furthermore, Vinpocetine demonstrates significant neuroprotective capabilities through its antioxidant and anti-inflammatory effects. During an ischemic event, the brain is subjected to a surge of reactive oxygen species and inflammatory mediators, which can cause substantial cellular damage. Vinpocetine's ability to neutralize free radicals and suppress inflammatory pathways helps to mitigate this secondary injury, preserving neuronal integrity. These powerful vinpocetine antioxidant, anti-inflammatory effects are critical for limiting brain damage.
The implications of Vinpocetine extend to improving overall cognitive function and potentially ameliorating post-stroke complications such as depression and epilepsy. Research on vinpocetine cognitive function improvement highlights its role in enhancing memory and attention, while studies investigating its impact on post-stroke conditions, including vinpocetine post-stroke depression prevention, are ongoing. These benefits underscore its potential as a comprehensive support agent during neurological recovery.
At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to providing pharmaceutical-grade Vinpocetine that meets stringent purity and quality standards. Our product supports scientific research aimed at understanding and leveraging the full spectrum of Vinpocetine's benefits, particularly its profound vinpocetine neuroprotective effects. By offering a reliable source of this compound, we aim to contribute to the development of more effective treatments for ischemic stroke and its related neurological challenges.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.